Mitsui Global Investment

06/04/2026 | Press release | Distributed by Public on 06/03/2026 19:01

Waypoint Bio raises $20M to run three CAR-T trials in China

New York City-based startup Waypoint Bio has raised $20 million in Series A financing to test multiple cell therapies in China, the company told Endpoints…

Mitsui Global Investment published this content on June 04, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 04, 2026 at 01:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]